Miroslav Šašinka, Katarína Furková, Igo Kajaba
Uremic dyslipidaemia differs from dyslipidaemias in other chronic diseases. It’s characterized by increased triglycerides levels, decreased HDL-cholesterol levels and increased or normal LDL-cholesterol levels. Uremic dyslipidaemia is crucial for chronic kidney diseases (CKD) patients prognosis and its management has leading position among the methods CKD therapy. In the dyslipidaemia pathogenesis is stressed importance of lipolysis and oxidative stress disorders, in the pathology atherosclerotic and arteriosclerotic changes of vessels. In therapy are analysed statin effects and their limitations in children, underlines primary importance of the nutrition especially n-3 unsaturated fatty acids, use of diverse diets types and suitability of various convenient nutrients.